Elvira Richter Johannes Wessling Norbert Lügering Wolfram Domschke Sabine Rüsch-Gerdes
10.3201/eid0807.010388
Emerg Infect Dis
2002 Jul;8(7):729-31.
CC BY
https://pubmed.ncbi.nlm.nih.gov/12095444/
AIDS-Related Opportunistic Infections / complications AIDS-Related Opportunistic Infections / microbiology HIV Infections / complications Mycobacterium avium subsp. paratuberculosis / isolation & purification Tuberculosis / complications Tuberculosis / microbiology
AIDS-Related Opportunistic Infections / complications AIDS-Related Opportunistic Infections / microbiology HIV Infections / complications Mycobacterium avium subsp. paratuberculosis / isolation & purification Tuberculosis / complications Tuberculosis / microbiology Case Reports Adult Anti-Infective Agents / therapeutic use Antitubercular Agents / therapeutic use Ciprofloxacin / therapeutic use Fatal Outcome Germany HIV Infections / microbiology Humans Male Mycobacterium avium subsp. paratuberculosis / classification Ofloxacin / therapeutic use Polymerase Chain Reaction Tuberculosis / drug therapy Anti-Infective Agents Antitubercular Agents Ciprofloxacin Ofloxacin
PMC2730323
12095444
Mycobacterium avium subsp. paratuberculosis infection in a patient with HIV, Germany
2002